Calamos Advisors’s Guardian Pharmacy Services GRDN Stock Holding History

Calamos Advisors’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27,949	Closed	-$596K	–	1021
2025 Q2	$596K	Sell	27,949 -11,970	-30%	-$270K	﹤0.01%	732
2025 Q1	$849K	Buy	39,919 +15,194	+61%	+$312K	﹤0.01%	664
2024 Q4	$501K	Buy	24,725 +13,720	+125%	+$283K	﹤0.01%	733
2024 Q3	$185K	Buy	+11,005	New	+$185K	﹤0.01%	791

Other funds holding GRDN

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Calamos Advisors's GRDN Position: Q3 2025 in Review

Calamos Advisors sold out of Guardian Pharmacy Services (GRDN) in Q3 2025, closing a stake of 27,949 shares — an estimated $596K sold.

Calamos Advisors first reported a position in GRDN in Q3 2024 and held it in 4 quarters. The position peaked at $849K in Q1 2025. 112 funds tracked by Wall St. Rank hold GRDN as of Q3 2025.

Calamos Advisors reported no remaining Guardian Pharmacy Services position as of Q3 2025 after selling out during the quarter.
Calamos Advisors sold 27,949 Guardian Pharmacy Services shares in Q3 2025, an estimated $596K.
Calamos Advisors first reported a position in Guardian Pharmacy Services in Q3 2024 and held it in 4 quarters.
Calamos Advisors's Guardian Pharmacy Services position peaked at $849K in Q1 2025.
112 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2025.

Based on Calamos Advisors's 13F filing for Q3 2025, filed 20 Oct 2025.